Results 211 to 220 of about 901,705 (329)

Celebrating milestones and embracing innovation: the next chapter for Drugs in Context. [PDF]

Drugs Context
Anderson SL, Mangoni AA, Torres T.
europepmc   +1 more source

From the editorial board

Journal of Radiation Oncology, 2012
Jiade J. Lu, L. Brady
semanticscholar   +1 more source

ESG Messaging on Social Media and Cost of Capital: A Canadian Perspective

Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, EarlyView.
ABSTRACT We examine whether environmental, social and governance (ESG) communications on social media decrease firms' cost of equity. Our results show that ESG messaging on social media does not appear to influence investors, which leads us to examine why.
Dhruv Baswal, Sean Cleary
wiley   +1 more source

Power imbalances in tropical medicine journals: an analysis of editorial board representation. [PDF]

Trop Med Health
Panda SN, Barik M, Ratna P, Das PK.
europepmc   +1 more source

Trends and Insights in Arab Audit Research: A Bibliometric Exploration

Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, EarlyView.
ABSTRACT This study employs bibliometric analysis to investigate audit research trends across five Arab countries—Jordan, Saudi Arabia, Egypt, Tunisia and the United Arab Emirates—each reflecting distinct sociopolitical, economic and legal contexts.
Zouhour Ben Hamadi, Peter Ghattas
wiley   +1 more source

Editorial Self-Publication in Scientific Journals: Insights and Implications for Otorhinolaryngology Practice. [PDF]

Turk Arch Otorhinolaryngol
Bayram A.
europepmc   +1 more source

Population Pharmacokinetic and Exposure‐Response Analysis of the Cognitive Effects of TAK‐071 in Participants With Parkinson Disease and Cognitive Impairment

Clinical Pharmacology in Drug Development, EarlyView.
Abstract TAK‐071 is a novel muscarinic M1 positive allosteric modulator under investigation for the treatment of cognitive impairment and falls associated with Parkinson disease (PD). This study evaluated population pharmacokinetics of TAK‐071 following single (1‐160 mg) and multiple (3‐15 mg once daily) oral‐dose TAK‐071 in 112 healthy participants ...
Hongxia Jia, Axel Facius, Rachel Jennings, Yaming Hang, Jaya Padmanabhan, Niraj M. Shanbhag, Brian T. Harel, Arthur Simen, Wei Yin   +8 more
wiley   +1 more source

Fundamentals of acoustic and hydrodynamic cavitation. [PDF]

Ultrason Sonochem
Sun X, Manickam S, Tao Y, Wu X.
europepmc   +1 more source

Contrôler la visibilité des aspects avec Aspectboxes, X-Editorial-Board = yes, X-International-Audience = no, X-Language = FR, X-Proceedings = yes

, 2009
Alexandre Bergel
openalex   +1 more source

Exposure–Response Analysis for Aripiprazole Once‐Monthly in Patients Diagnosed With Bipolar I Disorder

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Aripiprazole once‐monthly (AOM) is approved for the maintenance monotherapy treatment of bipolar I disorder (BP‐I) in adults. A previously developed population pharmacokinetic model was validated by applying it to data from patients diagnosed with BP‐I.
Xiaofeng Wang, Luann Phillips, Matthew Harlin, Karimah S. Bell Lynum, Frank Larsen, Pedro Such, Jessica Madera‐McDonough, Murat Yildirim, Ric M. Procyshyn, Craig Chepke, Julie Passarell   +10 more
wiley   +1 more source